Combination PIV3/HMPV RNA Vaccines
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 14 of these applications claim priority to application PCT/US2016/058327, filed Oct 21, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,064,934 | Combination PIV3/HMPV RNA Vaccines In force · Medium confidence | ModernaTX, Inc. | In force | Medium confidence | ||
| US 10,272,150 | Combination PIV3/HMPV RNA Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 10,543,269 | HMPV RNA Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 10,702,599 | HPIV3 RNA Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 10,702,600 | Betacoronavirus Mrna Vaccine In force · Medium confidence | ModernaTX, Inc. | In force | Medium confidence | ||
| US 10,933,127 | Betacoronavirus Mrna Vaccine In force · Medium confidence | ModernaTX, Inc. | In force | Medium confidence | ||
| US 11,872,278 | Combination Hmpv/Rsv RNA Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 12,208,288 | Betacoronavirus RNA Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 12,403,335 | Betacoronavirus Mrna Vaccines In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| US 12,403,336 | BETACORONA VIRUS mRNA VACCINES In force · Low confidence | ModernaTX, Inc. | In force | Low confidence | ||
| 5 more patents in this group · Pro | ||||||
10 of 15 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 15.
14 of these are in force and held by ModernaTX, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.